Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 CPT code 87912

Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus

Refer to current CPT coding guidelines for proper use and reporting of this code. Modifier 59 should be used to indicate distinct procedural services performed on the same day.Modifier 91 is appropriate for repeat laboratory tests on the same day.

Modifiers 59 and 91 may be applicable.

Medical necessity is established by the clinical need to determine the genotype of the Hepatitis B virus, especially for patients not responding to standard therapies or for those newly diagnosed to guide treatment planning.

The laboratory analyst performs all technical aspects of the test, including specimen handling, nucleic acid amplification, and sequence analysis.

In simple words: This test analyzes the genetic makeup of the hepatitis B virus in a patient's sample to see if it has changed in ways that make it resistant to treatment.

This code represents the laboratory analysis of a specimen to determine the genotype of the Hepatitis B virus using nucleic acid testing (DNA or RNA).The process may involve techniques like polymerase chain reaction (PCR) to amplify the viral nucleic acid, followed by sequencing to identify specific genetic markers. This information helps determine if the virus has mutated, especially concerning drug resistance.

Example 1: A patient being treated for chronic hepatitis B is not responding to antiviral therapy.The physician orders this test to check for drug resistance mutations in the virus., A patient newly diagnosed with hepatitis B is having this test done to determine the specific genotype of the virus, which can inform treatment decisions and prognosis., A patient with a history of hepatitis B needs antiviral treatment and the test helps in making informed decision for further treatment.

Documentation should include the physician's order for the test, the reason for testing (e.g., suspected drug resistance, initial genotyping), the date the specimen was collected, the type of specimen, and the laboratory's report including the genotype identified.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.